NCT05716646Not yet recruiting
In the Real World Study, the Efficacy and Adverse Reactions of Ticagrelor on Ischemic Cerebrovascular Disease
Real-world Study on the Efficacy and Safety of Ticagrelor in the Treatment of Ischemic Cerebrovascular Disease
Source: ClinicalTrials.gov · Last updated 8 Feb 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a forward-looking, open, one-arm, and real clinical trial world. The researchers plan to recruit at least 50 qualified patients. The main purpose of this study is to establish a population pharmacokinetic model of ticagrelor , explore the correlation between its blood concentration and the events of ischemia and the adverse effects of hemorrhage, and evaluate the effectiveness and safety of ticagrelor in the treatment of ischemic cerebrovascular disease.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 29 Jan 2023
- Start date
- Apr 2023
- Primary completion date
- Dec 2028
- Lead sponsor
- Qianfoshan Hospital
- Diseases
- Stroke
- NCT number
- NCT05716646
What you commit to
- Study type: Observational
- Planned participants: 50
- From Apr 2023 to the primary completion date, Dec 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Head CT or MRI suggests the presence of intracranial hemorrhagic disease.
- People with tumors and other serious systemic diseases.
- Allergy to ticagelor.
Who the study is looking for
- Female or male aged ≥ 18 years.
- Clinically diagnosed as ischemic cerebrovascular disease.
- Take ticagelor for antiplatelet therapy.
- Provision of informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.